Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (181-190 of 456) with videos related to

Pageof 46
Sort By:
Cancer Treatment Reports|January 1, 1981
The role of target determinants in antineoplastic therapyB A Chabner, Y M Rustum, H K Slocum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
The phase III trial in the era of targeted therapy: unraveling the "go or no go" decisionThomas G Roberts, Thomas J Lynch, Bruce A Chabner
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Biochemical Pharmacology|February 1, 1980
Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brainC M Liang, Y P Liu, B A Chabner
The Oncologist|March 2, 2019
The Other Opioid Crisis: Just Another Drug Shortage?Tara E Soumerai, Mihir M Kamdar, Bruce A Chabner
The Journal of Biological Chemistry|December 10, 1971
Purification and properties of carboxypeptidase G 1 J L McCullough, B A Chabner, J R Bertino
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1974
Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapyS H Rosenoff, M L Wolf, B A Chabner
Nature|October 13, 1972
Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicityB A Chabner, D G Johns, J R Bertino
Pageof 46

Showing results (181-190 of 456) with videos related to

Sort By:
Pageof 46
Cancer Treatment Reports|January 1, 1981
The role of target determinants in antineoplastic therapyB A Chabner, Y M Rustum, H K Slocum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
The phase III trial in the era of targeted therapy: unraveling the "go or no go" decisionThomas G Roberts, Thomas J Lynch, Bruce A Chabner
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Biochemical Pharmacology|February 1, 1980
Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brainC M Liang, Y P Liu, B A Chabner
The Oncologist|March 2, 2019
The Other Opioid Crisis: Just Another Drug Shortage?Tara E Soumerai, Mihir M Kamdar, Bruce A Chabner
The Journal of Biological Chemistry|December 10, 1971
Purification and properties of carboxypeptidase G 1 J L McCullough, B A Chabner, J R Bertino
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1974
Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapyS H Rosenoff, M L Wolf, B A Chabner
Nature|October 13, 1972
Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicityB A Chabner, D G Johns, J R Bertino
Pageof 46